X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1010) 1010
Publication (169) 169
Book Review (24) 24
Book Chapter (3) 3
Magazine Article (2) 2
Newsletter (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (649) 649
foscarnet (577) 577
antiviral agents - pharmacology (422) 422
foscarnet - pharmacology (319) 319
pharmacology & pharmacy (314) 314
animals (263) 263
phosphonoacetic acid - analogs & derivatives (237) 237
antiviral agents - therapeutic use (216) 216
cytomegalovirus - drug effects (195) 195
virology (193) 193
ganciclovir (190) 190
phosphonoacetic acid - pharmacology (181) 181
male (178) 178
ganciclovir - pharmacology (165) 165
acyclovir - pharmacology (164) 164
female (156) 156
foscarnet - therapeutic use (150) 150
index medicus (147) 147
microbiology (146) 146
adult (132) 132
virus replication - drug effects (124) 124
viruses (123) 123
cytomegalovirus (122) 122
cytomegalovirus infections - drug therapy (122) 122
drug resistance, microbial (120) 120
antiviral agents (117) 117
infection (113) 113
aids (112) 112
virus diseases (112) 112
infectious diseases (111) 111
cell line (110) 110
organophosphorus compounds - pharmacology (106) 106
mutation (105) 105
ganciclovir - therapeutic use (99) 99
cidofovir (98) 98
cytosine - analogs & derivatives (98) 98
acyclovir (97) 97
microbial sensitivity tests (95) 95
cytomegalovirus - genetics (91) 91
cells, cultured (90) 90
resistance (86) 86
simplexvirus - drug effects (86) 86
antiviral agents - administration & dosage (81) 81
dna-directed dna polymerase - genetics (81) 81
drug resistance, viral (81) 81
therapy (79) 79
mice (77) 77
middle aged (74) 74
research article (74) 74
acquired-immunodeficiency-syndrome (73) 73
cytosine - pharmacology (73) 73
immunology (73) 73
herpes simplex - drug therapy (71) 71
kinetics (67) 67
organophosphonates (62) 62
acyclovir - therapeutic use (61) 61
herpesvirus 1, human - drug effects (61) 61
hiv-1 - drug effects (60) 60
cytomegalovirus infections - virology (59) 59
retinitis (59) 59
biochemistry & molecular biology (56) 56
drug resistance (56) 56
infections (56) 56
dose-response relationship, drug (54) 54
in-vitro (54) 54
transplantation (54) 54
antivirals (52) 52
foscarnet - administration & dosage (52) 52
disease (51) 51
herpes simplex virus (51) 51
phosphonoacetic acid - therapeutic use (51) 51
rats (51) 51
acquired immunodeficiency syndrome - complications (50) 50
viral proteins - genetics (50) 50
biochemical phenomena, metabolism, and nutrition (49) 49
drug resistance, viral - genetics (49) 49
virus (49) 49
aids-related opportunistic infections - drug therapy (47) 47
human-immunodeficiency-virus (47) 47
molecular sequence data (47) 47
drug-resistance (46) 46
mutations (46) 46
dna (45) 45
zidovudine - pharmacology (45) 45
antiviral drugs (44) 44
dna-directed dna polymerase - metabolism (44) 44
health aspects (44) 44
cytomegalovirus - isolation & purification (43) 43
invitro (43) 43
replication (43) 43
viral plaque assay (43) 43
cytomegalovirus infections (42) 42
nucleic acid synthesis inhibitors (42) 42
antiviral activity (41) 41
drug therapy (41) 41
immunocompromised host (41) 41
cytosine - therapeutic use (40) 40
drug therapy, combination (40) 40
organophosphorus compounds - therapeutic use (40) 40
hiv (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (977) 977
Spanish (13) 13
French (7) 7
Japanese (7) 7
German (5) 5
Russian (5) 5
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mayo Clinic Proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 10, pp. 1009 - 1026
Abstract Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | HERPES-SIMPLEX-VIRUS | TENOFOVIR DISOPROXIL FUMARATE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | POSITIVE CHRONIC HEPATITIS | CHRONIC HEPATITIS-B | ALPHA-2A PLUS RIBAVIRIN | CONGO HEMORRHAGIC-FEVER | ACUTE INTERSTITIAL NEPHRITIS | RECURRENT GENITAL HERPES | HIV-INFECTED PATIENTS | Acyclovir - therapeutic use | Foscarnet - pharmacology | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Ganciclovir - analogs & derivatives | Interferons - therapeutic use | Oligopeptides - therapeutic use | Hepatitis - drug therapy | Adenine - therapeutic use | Lamivudine - therapeutic use | Ganciclovir - therapeutic use | Proline - pharmacology | Protease Inhibitors - therapeutic use | Guanine - therapeutic use | Oseltamivir - pharmacology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Interferons - pharmacology | Pyrimidinones - therapeutic use | Acyclovir - pharmacology | Zanamivir - therapeutic use | Herpesviridae Infections - drug therapy | Thymidine - analogs & derivatives | Valine - therapeutic use | Oligopeptides - pharmacology | Ribavirin - pharmacology | Guanine - analogs & derivatives | Oseltamivir - therapeutic use | Guanine - pharmacology | Hepatitis C - epidemiology | Nucleosides - pharmacology | Ganciclovir - pharmacology | Pyrimidinones - pharmacology | Influenza, Human - drug therapy | Drug Therapy, Combination | Nucleosides - therapeutic use | Acyclovir - analogs & derivatives | Ribavirin - therapeutic use | Valine - analogs & derivatives | Zanamivir - pharmacology | Adenine - pharmacology | Proline - therapeutic use | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | HIV Infections - drug therapy | Lamivudine - pharmacology | Foscarnet - therapeutic use | Valine - pharmacology | Amantadine - pharmacology | Antiviral agents | Diagnosis | Research | Drug therapy | HIV infection | Health aspects | Symposium on Antimicrobial Therapy
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2016, Volume 39, Issue 5, pp. 770 - 777
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 07/2006, Volume 214, Issue 2, pp. 166 - 177
Although uranium is a well-characterized nephrotoxic agent, very little is known at the cellular and molecular level about the mechanisms underlying the uptake... 
Sodium-dependent phosphate co-transport | Uranium | NaPi | Cytotoxicity | LLC-PK | MDCK | Uranyl | Speciation | RENAL EPITHELIAL-CELLS | LLC-PK1 | NITRATE | RAT-KIDNEY | uranyl | DOWN-REGULATION | speciation | sodium-dependent phosphate co-transport | INORGANIC ANION-EXCHANGER | PARATHYROID-HORMONE | I-COTRANSPORTER | PHARMACOLOGY & PHARMACY | TOXICOLOGY | uranium | PROXIMAL TUBULE | APICAL MEMBRANE | ADAPTIVE RESPONSE | cytotoxicity | Colchicine - pharmacology | Tetradecanoylphorbol Acetate - pharmacology | Foscarnet - pharmacology | Concanavalin A - pharmacology | Maleimides - pharmacology | Carbonates - pharmacology | Cytochalasin D - pharmacology | Tetradecanoylphorbol Acetate - antagonists & inhibitors | Sodium-Phosphate Cotransporter Proteins, Type IIa - metabolism | Dose-Response Relationship, Drug | LLC-PK1 Cells | Uranium - toxicity | Dexamethasone - pharmacology | Swine | Computer Simulation | Indoles - pharmacology | Sodium-Phosphate Cotransporter Proteins, Type IIb - physiology | Phosphates - pharmacology | Cell Survival - drug effects | Kidney Tubules, Proximal - cytology | Cadmium - toxicity | Phosphates - physiology | Meglumine - analogs & derivatives | Calcium Chloride - pharmacology | Animals | Meglumine - pharmacology | Uranium Compounds | Phosphates - antagonists & inhibitors | Kidney Tubules, Proximal - metabolism | Kidney Tubules, Proximal - drug effects
Journal Article
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, ISSN 1166-7087, 11/2013, Volume 23, Issue 15, p. 1342
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2014, Volume 58, Issue 12, pp. 7312 - 7323
The susceptibilities of gammaherpesviruses, including Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV), and animal rhadinoviruses, to... 
REAL-TIME PCR | THYMIDINE KINASE | NARROW SUBSTRATE-SPECIFICITY | HERPES-SIMPLEX-VIRUS | PROTEIN-KINASE | VARICELLA-ZOSTER-VIRUS | SARCOMA-ASSOCIATED HERPESVIRUS | TYPE-1 DNA-POLYMERASE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | REPLICATION FIDELITY | EPSTEIN-BARR-VIRUS | Protein Kinases - metabolism | Herpesvirus 8, Human - drug effects | Protein Kinases - genetics | Cytarabine - pharmacology | Foscarnet - chemistry | Herpesvirus 4, Human - genetics | Foscarnet - pharmacology | Humans | Herpesvirus 4, Human - drug effects | Molecular Sequence Data | Protein Kinases - chemistry | Structure-Activity Relationship | Cytarabine - analogs & derivatives | DNA-Directed DNA Polymerase - chemistry | Viral Proteins - metabolism | DNA-Directed DNA Polymerase - genetics | Arabinofuranosyluracil - analogs & derivatives | Arabinofuranosyluracil - pharmacology | Bromodeoxyuridine - analogs & derivatives | Acyclovir - chemistry | Herpesvirus 4, Human - enzymology | Antiviral Agents - chemistry | Arabinofuranosyluracil - chemistry | Bromodeoxyuridine - chemistry | Ganciclovir - pharmacology | Amino Acid Sequence | Rhadinovirus - genetics | Antiviral Agents - pharmacology | Ganciclovir - chemistry | Thymidine Kinase - genetics | Acyclovir - analogs & derivatives | Thymidine Kinase - chemistry | Viral Proteins - chemistry | Acyclovir - pharmacology | Viral Proteins - genetics | Herpesvirus 8, Human - genetics | Drug Resistance, Viral - genetics | Rhadinovirus - drug effects | Sequence Alignment | Animals | Cytarabine - chemistry | Rhadinovirus - enzymology | Bromodeoxyuridine - pharmacology | Thymidine Kinase - metabolism | DNA-Directed DNA Polymerase - metabolism | Herpesvirus 8, Human - enzymology | Antiviral Agents
Journal Article
Antiviral Research, ISSN 0166-3542, 2010, Volume 86, Issue 3, pp. 246 - 252
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 02/2009, Volume 10, Issue 2, pp. 191 - 209
This review discusses the management of resistant cytomegalovirus and prevention strategies for fatal therapy failures. Five drugs, ganciclovir/valganciclovir,... 
treatment | artesunate | cytomegalovirus | cidofovir | ganciclovir | foscarnet | maribavir | resistance | Resistance | Cytomegalovirus | Foscarnet | Ganciclovir | Treatment | Artesunate | Maribavir | Cidofovir | ACQUIRED-IMMUNODEFICIENCY-SYNDROME | ORAL GANCICLOVIR | OPEN READING FRAME | GANCICLOVIR RESISTANCE | BONE-MARROW-TRANSPLANTATION | HEMATOPOIETIC STEM-CELL | PREEMPTIVE THERAPY | ORGAN TRANSPLANT RECIPIENTS | DNA-POLYMERASE MUTATIONS | PHARMACOLOGY & PHARMACY | BENZIMIDAZOLE L-RIBOSIDE | Cytosine - analogs & derivatives | Foscarnet - pharmacology | Humans | Ganciclovir - analogs & derivatives | Cytosine - administration & dosage | Thionucleotides - administration & dosage | Cytomegalovirus Infections - prevention & control | Cytomegalovirus Infections - virology | Ganciclovir - therapeutic use | Ganciclovir - pharmacology | Cytosine - pharmacology | Cytosine - therapeutic use | Drug Therapy, Combination | Antiviral Agents - pharmacology | Organophosphonates - therapeutic use | Thionucleotides - therapeutic use | Antiviral Agents - therapeutic use | Thionucleotides - pharmacology | Antiviral Agents - administration & dosage | Foscarnet - administration & dosage | Organophosphonates - administration & dosage | Organophosphonates - pharmacology | Cytomegalovirus Infections - drug therapy | Drug Resistance, Viral - drug effects | Foscarnet - therapeutic use | Ganciclovir - administration & dosage
Journal Article